Pfizer’s COVID-19 vaccines expected to generate $15 billion in 2021
Stock experts had earlier anticipated that Pfizer would earn $12.7 billion from its COVID-19 vaccines sales in 2021.
Stock experts had earlier anticipated that Pfizer would earn $12.7 billion from its COVID-19 vaccines sales in 2021.
Business News | Stock Market | Money Market | Cryptos | Financial Literacy | SME |